Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone reflects strong support and excitement, with discussions citing precise response rates like '67% responded to ketamine,' and emphasizing the treatment's promising effects. Words like 'game changer' and references to clinical trial details indicate high engagement and interest, while the recurring mention of the study’s positive findings underscores its perceived importance.
Most discussions highlight positive results and support the study’s findings, indicating general agreement on ketamine’s potential for treating PTSD.
The posts demonstrate high interest, referencing specific statistics, study details, and potential for future applications, showing engagement.
Many posts delve into study outcomes, compare treatments, and speculate on real-world impact, reflecting deep engagement.
The discussion emphasizes the promising nature and clinical significance of the findings, suggesting substantial potential impact on PTSD treatment.
#PTSD is very hard to treat. Great to see new treatment options emerging: 67% responded to IV #ketamine vs 20% in midazolam-control group A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder https://t.co/XVnpNdVh4r
治療の難しいPTSDの人へのケタミン治療の有効性と安全性を調べた論文。いずれも有効な研究結果が得られ、抗うつ薬に比べても有効であったようだ。 https://t.co/5WnfEtfh5A
Ketamine can be effective for PTSD and appears to work better than traditionally prescribed benzodiazepines such as Midazolam. 67% of PTSD patients responded to ketamine infusions, while only 20% of PTSD patients responded to Midazolam infusions. https://t.co/928GdFdbUj
Is there some rule against using more than 20 participants per condition for studies of ketamine treatment of distress disorders? Here's a brand new one with N=15/cell. Seriously? https://t.co/0xsamrIoR5
New study out on the efficacy of #ketamine for #PTSD. #Psychiatry #medicine #MentalHealthMatters https://t.co/P4RP7Mxv9v
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder | American Journal of Psychiatry https://t.co/50WJOKSUQj
This video discusses a JAMA Psychiatry study exploring the safety and effectiveness of repeated ketamine infusions for treating chronic PTSD, highlighting significant symptom improvements and sustained benefits with…
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder | American Journal of Psychiatry https://t.co/r0a2sVdJ7h
Repeated ketamine infusions show a significant reduction in chronic PTSD symptoms, offering hope for effective treatment. Learn more about this study here: https://t.co/LCTVWSlccb. #KetamineAdministration #DestinFL #IVKetamineTherapy https://t.co/7VoZBH43ge
Uncover a potential breakthrough in the battle against chronic PTSD at Destin Ketamine Solutions. Connect with us today! Source: https://t.co/2Fjl2pBti5 #DestinFL #KetamineTherapy #ChronicPTSD https://t.co/1OgfHZa8Go
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder | American Journal of Psychiatry https://t.co/5bgNkyn1k0 10 out of 15 responded to ketamine! And effects were still present at 1 month follow up!
@EddCamargo Aquí un RCT de la eficacia vs placebo de #PTSD con #Ketamina https://t.co/n7O7jza4Yl
7/8 Chronic PTSD 2021 study found that ketamine was far more effective in reducing PTSD symptoms than an anti-anxiety control drug. 67% of participants who received ketamine reported improvement, with positive effects lasting beyond 27 days. https://t.co/iEgwrzvZYo
Glad to see folks getting relief from PTSD, more research supporting efficacy of ketamine infusions https://t.co/LQyld1Oxsk
RT @carlos_arnaud: https://t.co/n7O7jza4Yl
RT @carlos_arnaud: https://t.co/n7O7jza4Yl
https://t.co/n7O7jza4Yl
Feder et al. (2021) found improvements in chronic PTSD symptoms in individuals after 2 weeks of repeated ketamine doses: https://t.co/8W6xCWVXHh https://t.co/bnQfV1bgkC
Feder et al: Patients with chronic PTSD given repeated infusions of ketamine over 2 weeks showed significantly greater symptom improvement than those given a psychoactive placebo control infusion, the first evidence of efficacy. https://t.co/0ExgUPJ39x 2/5
RT @Psychedelic_Med: A 2021 study examines the efficacy of #ketamine for treating #PTSD. The randomized controlled trial showed positive re…
RT @Psychedelic_Med: A 2021 study examines the efficacy of #ketamine for treating #PTSD. The randomized controlled trial showed positive re…
RT @Psychedelic_Med: A 2021 study examines the efficacy of #ketamine for treating #PTSD. The randomized controlled trial showed positive re…
A 2021 study examines the efficacy of #ketamine for treating #PTSD. The randomized controlled trial showed positive results, with patients seeing reduced symptom severity following the 2-week course of infusions. https://t.co/QTthu6ts2j
Just in case you or a loved one (Combat Vet) suffers with PTSD here's a short read. #hopeful #gratitude
Recent randomised control trial published in #AmericanJournalofPsychiatry provided sufferers of chronic posttraumatic stress disorder with ketamine infusions. The results are a possible breakthrough & may have potential as an effective treatment. https://t.co/ISQoLsNi9Q
RT @hgamez7: Evidencia sobre la efectividad de infusiones reptidas de Ketamina para mejorar el trastorno de estrés postraumático #TEPT ht…
Evidencia sobre la efectividad de infusiones reptidas de Ketamina para mejorar el trastorno de estrés postraumático #TEPT https://t.co/OqQ5XL445Q
Exciting early evidence of repeated ketamine infusions in decreasing symptom severity in individuals w chronic PTSD, more studies are needed. #ptsd #cptsd #ketamine #PTSDresearch https://t.co/QKiFV0ramy
small RCT: repeated ketamine infusions reduced symptom severity in individuals with chronic PTSD vs. midazolam at week 2 (mean CAPS-5 total score = 11.88 points lower; d=1.13; 0.36-1.91). Ketamine infusions were well tolerated overall https://t.co/qUI8O9KxG5
RT @GlobalMedEd: Ketamine shows efficacy in controlled trial for PTSD. https://t.co/Ez7XmPjQ2t #nursepractitioner #primarycare #mh #bipolar…
RT @GlobalMedEd: Ketamine shows efficacy in controlled trial for PTSD. https://t.co/Ez7XmPjQ2t #nursepractitioner #primarycare #mh #bipolar…
Ketamine shows efficacy in controlled trial for PTSD. https://t.co/Ez7XmPjQ2t #nursepractitioner #primarycare #mh #bipolar #depression #mood #mhchat #mentalhealth #anxiety #stress #PTSD #ketamine #esketamine https://t.co/IKvhobhcta
Las infusiones repetidas de ketamina serían eficaces reduciendo la severidad de los síntomas en el estrés postraumático crónico https://t.co/EHtgjDE8aF
“Among ketamine responders, the median time to loss of response was 27.5 days following the 2-week course of infusions.” Sounds like a recipe for ongoing #ketamine infusions, which, can be draining in and of itself. https://t.co/etjJvrlnaw
Very interesting RCT regarding ketamine in PTSD. Small sample size but the results are promising. https://t.co/Ex3y4xrAyh #PTSD #ketamine
RT @PerezMGHLab: A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder | American Jou…
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder | American Journal of Psychiatry https://t.co/nNvjL0Botg
RT @Psychedelic_Med: New study out on the efficacy of #ketamine for #PTSD. #Psychiatry #medicine #MentalHealthMatters https://t.co/P4RP7M…
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder https://t.co/I79lSVGcII
RCT: ketamine showed greater improvement in CAPS-5 and MADRS total scores than midazolam at week 2 in individuals with chronic PTSD (d=1.13; 0.36-1.91). response rates: 67% with ketamine vs. 20% with midazolam https://t.co/qUI8O9KxG5
Extra! Extra! Read all about it! Another randomized controlled research study, this one published January 2021 in The American Journal of Psychiatry showing ketamine's effectiveness in treating chronic PTSD. https://t.co/wEkcFWvCVh
This first double-blind (active) placebo-controlled study (n=30) of repeated ketamine (6x, 35mg/70kg) infusions found it to be effective as a treatment for PTSD (67% clinical response), but this response faded (on average) within a month https://t.co/MQQJbfMbDA
RT @drmikehart: Ketamine can be effective for PTSD and appears to work better than traditionally prescribed benzodiazepines such as Midazol…
RT @drmikehart: Ketamine can be effective for PTSD and appears to work better than traditionally prescribed benzodiazepines such as Midazol…
RT @drmikehart: Ketamine can be effective for PTSD and appears to work better than traditionally prescribed benzodiazepines such as Midazol…
Ketamine can be effective for PTSD and appears to work better than traditionally prescribed benzodiazepines such as Midazolam. 67% of PTSD patients responded to ketamine infusions, while only 20% of PTSD patients responded to Midazolam infusions. https://t.co/928GdFdbUj
Seis infusiones de ketamina redujeron la gravedad de los síntomas del TEPT crónico después de 2 semanas, con una puntuación de CAPS-5 11.88 puntos inferior a la del grupo de midazolam (d = 1.13).
RT @Chacruna_net: Six ketamine infusions reduced chronic PTSD symptom severity after 2 weeks with CAPS-5 mean total score 11.88 points lowe…
Six ketamine infusions reduced chronic PTSD symptom severity after 2 weeks with CAPS-5 mean total score 11.88 points lower than than the midazolam group (d=1.13); 67% of ketamine group were also treatment responders versus only 20% in the midazolam group. https://t.co/8aLec2nP0v https://t.co/3cuDryxybc
https://t.co/rChO5ZbSA6
RT @Psychedelic_Med: New study out on the efficacy of #ketamine for #PTSD. #Psychiatry #medicine #MentalHealthMatters https://t.co/P4RP7M…
New study out on the efficacy of #ketamine for #PTSD. #Psychiatry #medicine #MentalHealthMatters https://t.co/P4RP7Mxv9v
Repeated ketamine infusions were effective at reducing PTSD symptom severity after two weeks. "The data presented in our current study builds on initial findings about ketamine for PTSD, indicating ketamine's effect can be maintained over several weeks," https://t.co/c1TAHgz5Od
RT @ichiipsy: 治療の難しいPTSDの人へのケタミン治療の有効性と安全性を調べた論文。いずれも有効な研究結果が得られ、抗うつ薬に比べても有効であったようだ。 https://t.co/5WnfEtfh5A
RT @JD_Rosenblat: #PTSD is very hard to treat. Great to see new treatment options emerging: 67% responded to IV #ketamine vs 20% in midazo…
RT @JRBneuropsiq: A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder | American Jo…
RT @JD_Rosenblat: #PTSD is very hard to treat. Great to see new treatment options emerging: 67% responded to IV #ketamine vs 20% in midazo…
Sounds promising: https://t.co/dwc6gvikgp
"At week 2, the mean CAPS-5 total score was 11.88 points lower in the ketamine group than in the midazolam group. Sixty-seven percent of participants in the ketamine group were treatment responders, compared with 20% in the midazolam group." https://t.co/nFro6rHx8H
Is there some rule against using more than 20 participants per condition for studies of ketamine treatment of distress disorders? Here's a brand new one with N=15/cell. Seriously? https://t.co/0xsamrIoR5
RT @JRBneuropsiq: A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder | American Jo…
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder | American Journal of Psychiatry https://t.co/50WJOKSUQj
RT @ichiipsy: 治療の難しいPTSDの人へのケタミン治療の有効性と安全性を調べた論文。いずれも有効な研究結果が得られ、抗うつ薬に比べても有効であったようだ。 https://t.co/5WnfEtfh5A
RT @ichiipsy: 治療の難しいPTSDの人へのケタミン治療の有効性と安全性を調べた論文。いずれも有効な研究結果が得られ、抗うつ薬に比べても有効であったようだ。 https://t.co/5WnfEtfh5A
RT @ichiipsy: 治療の難しいPTSDの人へのケタミン治療の有効性と安全性を調べた論文。いずれも有効な研究結果が得られ、抗うつ薬に比べても有効であったようだ。 https://t.co/5WnfEtfh5A
RT @ichiipsy: 治療の難しいPTSDの人へのケタミン治療の有効性と安全性を調べた論文。いずれも有効な研究結果が得られ、抗うつ薬に比べても有効であったようだ。 https://t.co/5WnfEtfh5A
RT @ichiipsy: 治療の難しいPTSDの人へのケタミン治療の有効性と安全性を調べた論文。いずれも有効な研究結果が得られ、抗うつ薬に比べても有効であったようだ。 https://t.co/5WnfEtfh5A
RT @ichiipsy: 治療の難しいPTSDの人へのケタミン治療の有効性と安全性を調べた論文。いずれも有効な研究結果が得られ、抗うつ薬に比べても有効であったようだ。 https://t.co/5WnfEtfh5A
治療の難しいPTSDの人へのケタミン治療の有効性と安全性を調べた論文。いずれも有効な研究結果が得られ、抗うつ薬に比べても有効であったようだ。 https://t.co/5WnfEtfh5A
Original article: A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder (n=30) https://t.co/VL3dv8tTwr
RT @JD_Rosenblat: #PTSD is very hard to treat. Great to see new treatment options emerging: 67% responded to IV #ketamine vs 20% in midazo…
RT @JD_Rosenblat: #PTSD is very hard to treat. Great to see new treatment options emerging: 67% responded to IV #ketamine vs 20% in midazo…
RT @JD_Rosenblat: #PTSD is very hard to treat. Great to see new treatment options emerging: 67% responded to IV #ketamine vs 20% in midazo…
# # #neurociencia #endocrinología #saludmental https://t.co/Tz0YGXL5UQ
En este estudio el tratamiento con Ketamina IV presentó eficacia clínica en 2 semanas en pacientes con Síndrome de Estrés Post-traumático. ¿Podría la Ketamina ser útil además de en Depresión también en TEPT? https://t.co/7qVR5PCAir
RT @JD_Rosenblat: #PTSD is very hard to treat. Great to see new treatment options emerging: 67% responded to IV #ketamine vs 20% in midazo…
#PTSD is very hard to treat. Great to see new treatment options emerging: 67% responded to IV #ketamine vs 20% in midazolam-control group A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder https://t.co/XVnpNdVh4r
biliş ve ruh halindeki olumsuz değişiklikler dahil olmak üzere TSSB ile ilişkili dört semptomdan üçünü önemli ölçüde azalttı. https://t.co/4l1r0drl0n
RT @APAPubJournals: Patients with chronic PTSD given repeated infusions of ketamine over 2 weeks showed significantly greater symptom impro…
RT @APAPubJournals: Patients with chronic PTSD given repeated infusions of ketamine over 2 weeks showed significantly greater symptom impro…
RT @APAPubJournals: Patients with chronic PTSD given repeated infusions of ketamine over 2 weeks showed significantly greater symptom impro…
Patients with chronic PTSD given repeated infusions of ketamine over 2 weeks showed significantly greater symptom improvement than those given a psychoactive placebo control infusion, the first evidence of efficacy. Learn More: https://t.co/qqcIsNfCHC https://t.co/r7Bggz4cIj
10.1176/appi.ajp.2020.20050596. Keywords. /Applied sciences and engineering/Engineering/Bioengineering/Systems biology; /Health and medicine/Diseases and ...
https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.20050596?url_ver=Z39 ... Psychedelics and psychedelic-assisted psychotherapy. https://ajp.psychiatryonline.
281-306. http://dx.doi.org/10.1176/appi.ajp.2009.09081168 [220] Bufka, L.F.; Wright, C.V.E.; Halfond, R.W. Casebook to the APA [204] Berman, R.M.; Cappiello ...
https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.20050596 ... 10.1176/appi.ajp.2019.19010035; Schouten KA, et al. (2017). Trauma ...
there's plenty of data showing ketamine tends to help with PTSD https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2020.20050596. I ...
... 10.1176/appi.ajp.2020.20050596. Yaklaşık 3 ayda bir infüzyon yaptırıyorum ve evde kullanılan troşlar genellikle bakım için haftada 2 kez ...
Er is genoeg data die laat zien dat ketamine helpt bij PTSD https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2020.20050596. Ik ...
... de ketamina para tratamento de TEPT resistente: www.ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2020.20050596".
... 10.1176/appi.ps.201300307 Rebekah Bradley ... ajp.162.2.214 https://ajp.psychiatryonline ... 2020.20050596 McGhee, Laura L. PhD and ...
... still it's not in the same category as glutathione injections. https://doi.org/10.1176/appi.ajp.2020.20050596 · Fuzzy_Yogurt_Bucket. • 4y ago.
Feder et al, AJP, 2021. doi.org/10.1176/appi.ajp.2020.20050596. Coline Garré. 0 RéactionsCommenter; Partager sur Facebook. Facebook. Partager ...
[link url="https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2020.20050596"]American Journal of Psychiatry study (Open access)[/link].
doi.org/10.1176/appi.ajp.2020.20050596. Be the first to rate this article. Posted in: Medical Research News | Medical Condition News. Comments ...
10.1176/appi.ajp.2020.20050596. Keywords. /Applied sciences and engineering/Engineering/Bioengineering/Systems biology; /Health and medicine ...
2020.2 DOI: 10.1176/appi.ajp.2020.20050596. Cite This Page: MLA; APA; Chicago. The Mount Sinai Hospital / Mount Sinai ...
... of Psychiatry: https://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.2020.20050596?journalCode=ajp · Toasttoasttoast1. • 5y ago.
JF
いバ
MD
AW
PA
JB
P
PD
IP
DA
P
BA
Q
FR
BB
JA
PS
T
SJ
DB
ML
JM
EP
ML
P
RJ
MH
GE
I
DP
SM
TN
DF
ﻮค
塩
R
B
TR
JB
P
CL
GS
CI
L
EI
消フ
CX
A
BL
GV
IЯ
LE
Sル
し
ま
黒
さ
北仁
PA
LJ
CK
MH
JG
JG
Lバ
UK
JG
KM
SC